Myelin Protein Zero-Like 2 (MPZL2) Peptide
MPZL2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940267
Quick Overview for Myelin Protein Zero-Like 2 (MPZL2) Peptide (ABIN940267)
Target
MPZL2
(Myelin Protein Zero-Like 2 (MPZL2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- LEAVNGTDAR LKCTFSSFAP VGDALTVTWN FRPLDGGPEQ FVFYYHIDPF
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MPZL2 antibody,
Alternative Names: MPZL2 control peptide, MPZL2 antibody Blocking Peptide, Anti-MPZL2 Blocking Peptide, Myelin Protein Zero-Like 2 Blocking Peptide, EVA Blocking Peptide, EVA1 Blocking Peptide, MPZL2, MPZL-2, MPZL 2, MPZL-2 Blocking Peptide, MPZL 2 Blocking Peptide -
Purification
- Rabbit Anti-Tau (Ab-396) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
-
Background
- Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis.
-
Molecular Weight
- 22 kDa
Target
-
You are here:
